Bronchiectasis: An Emerging Global Epidemic

Sanjay H. Chotirmall; James D. Chalmers


BMC Pulm Med. 2018;18(76) 

In This Article

Clinical Disease

In this special issue, the clinical aspects of bronchiectasis are covered from both the physician and patient perspective. The authoritative review by Schäfer and colleagues reviews bronchiectasis pathogenesis, its imaging and clinical characteristics from both a cystic fibrosis (CF) and non-CF perspective across a diverse range of aetiologies.[15] In a patient focused article, Hester et al. address the issue of adherence to the multi-modal treatment options used in the care of bronchiectasis patients by reviewing the provision of and requirement for patient education.[16] Minimal work to date has been performed in bronchiectasis focused in this area especially when compared to other chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The information deficits uncovered in this qualitative approach clearly represent one of the key barriers to the implementation of bronchiectasis self-management. Further original qualitative work is provided by Dudgeon et al. whose study focused on the patient's perspective of health-related quality of life (QOL).[17] Semi-structured interviews elucidated that bronchiectasis-related symptoms are highly individual and variable, a feature that current available treatment and QOL tools do not adequately capture.